Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)

To compare clinicopathological phenotype-based, anti-neutrophil cytoplasmic antibody (ANCA) serotype-based, and unsupervised data-driven classifications in relation to clinical outcomes and patient heterogeneity in a large Japanese cohort with ANCA-associated vasculitis (AAV). This multicentre, retrospective cohort study analysed data from a nationwide Japanese registry of 729 newly diagnosed patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), all positive for myeloperoxidase (MPO)- or proteinase 3 (PR3)-ANCA. Patients were classified by phenotype, serotype, combined phenotype-serotype groupings, and data-driven clustering based on baseline clinical and laboratory features. Associations with clinical outcomes—including mortality, relapse, and response to rituximab (RTX) versus cyclophosphamide (IVCY)—were evaluated using inverse probability of treatment weighting (IPW). Phenotype-based classification more accurately distinguished all-cause mortality risk (MPA vs. GPA: hazard ratio [HR] 2.53, 95% CI 1.34–4.76). Combined phenotype-serotype analysis identified MPO-MPA patients with the highest mortality (HR 3.45, 95% CI 1.09-11.0, vs. PR3-GPA) and PR3-GPA with the highest severe relapse. Discordant groups, such as MPO-GPA, demonstrated unique clinical characteristics. After IPW adjustment, no significant difference in 24-week remission rates was observed between RTX and IVCY across classifications, both overall (RR 1.02, 95% CI 0.95–1.09) and within subgroups. Unsupervised clustering identified four distinct clinical subgroups, with limited concordance with conventional phenotype or serotype classifications. Phenotype and serotype classifications provide complementary, not competing, prognostic insights in Japanese patients with AAV. Data-driven clustering revealed additional clinical heterogeneity not captured by traditional systems, underscoring the need for integrated, multi-dimensional stratification approaches to improve personalised risk assessment and treatment strategies.

• Publication year

  2025

• Venue

  Rheumatology International

• Publication date

  2025-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00296-025-06014-yPMID 41222744PMCID 12611989
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis

  2025cited by this paper
• In‐Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides Identifies Distinct Clinical Phenotypes

  2025cited by this paper
• Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study

  2025cited by this paper
• Differences in Phenotypes, Treatments, and Outcomes of ANCA-associated Vasculitis across Europe, Japan, and the United States in 2020.

  2025cited by this paper
• Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort.

  2024cited by this paper
• The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA‐Associated Vasculitis

  2023cited by this paper
• Single-cell multi-omics analysis identifies two distinct phenotypes of newly-onset microscopic polyangiitis

  2023cited by this paper
• EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

  2023cited by this paper
• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

  2022cited by this paper
• Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management

  2022cited by this paper
• Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry

  2022cited by this paper
• 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

  2022cited by this paper
• New Classification Criteria for Small‐Vessel Vasculitis: Is Antineutrophil Cytoplasmic Antibody Inclusion Their Major Advance?

  2022cited by this paper
• ANCA Status or Clinical Phenotype — What Counts More?

  2021cited by this paper
• Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis

  2021cited by this paper
• Classification of ANCA-associated vasculitis: differences based on ANCA specificity and clinicopathologic phenotype

  2021cited by this paper
• Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations

  2020cited by this paper
• Shirakawa,

  2020cited by this paper
• Japan

  2019cited by this paper
• Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?

  2019cited by this paper
• Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.

  2019cited by this paper
• Propensity Score Methods in Health Technology Assessment: Principles, Extended Applications, and Recent Advances

  2019cited by this paper
• Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

  2017cited by this paper
• Robust causal inference using directed acyclic graphs: the R package 'dagitty'.

  2017cited by this paper
• mclust 5: Clustering, Classification and Density Estimation Using Gaussian Finite Mixture Models

  2016cited by this paper
• Balancing Covariates via Propensity Score Weighting

  2014cited by this paper
• Model-based clustering of high-dimensional data: A review

  2014cited by this paper
• 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

  2013cited by this paper
• Collaborative Double Robust Targeted Maximum Likelihood Estimation

  2010cited by this paper
• Vasculitis Activity Score (version 3) Modification and validation of the Birmingham

  2010influential reference
• Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

  2008cited by this paper
• Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies

  2006cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• DIVISION OF NEPHROLOGY

  2003cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper

• No citing papers are available for this paper.